{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:39:36Z","timestamp":1790789976238,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier","isbn-type":[{"value":"9780128015834","type":"print"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1016\/bs.irn.2015.08.001","type":"book-chapter","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T21:00:35Z","timestamp":1442264435000},"page":"133-147","source":"Crossref","is-referenced-by-count":22,"title":["Effective Cessation Strategies for Smokers with Schizophrenia"],"prefix":"10.1016","author":[{"given":"A. Eden","family":"Evins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Cather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2015.08.001_bb0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/070674379704200107","article-title":"Readiness to stop smoking in schizophrenia","volume":"42","author":"Addington","year":"1997","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0010","first-page":"29","article-title":"Current cigarette smoking among adults\u2014United States, 2005\u20132012","volume":"63","author":"Agaku","year":"2014","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/bs.irn.2015.08.001_bb0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-159-6-201309170-00005","article-title":"Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: A randomized trial","volume":"159","author":"Anthenelli","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/bs.irn.2015.08.001_bb0020","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1176\/appi.ajp.163.11.1934","article-title":"A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder","volume":"163","author":"Baker","year":"2006","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0025","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.npp.1301423","article-title":"The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls","volume":"33","author":"Barr","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess mortality of schizophrenia","volume":"177","author":"Brown","year":"2000","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/bs.irn.2015.08.001_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.2013.283787","article-title":"Pharmacological treatments for smoking cessation","volume":"311","author":"Cahill","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2015.08.001_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpsychires.2013.09.014","article-title":"Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression","volume":"48","author":"Callaghan","year":"2014","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/15504263.2012.749559","article-title":"An open trial of relapse prevention therapy for smokers with schizophrenia","volume":"9","author":"Cather","year":"2013","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1016\/bs.irn.2015.08.001_bb0055","series-title":"A randomized controlled trial of motivational interviewing compared to psychoeducation for smoking in pre-contemplators with severe mental illness","author":"Cather","year":"2013"},{"key":"10.1016\/bs.irn.2015.08.001_bb0060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4088\/JCP.13m08756","article-title":"Varenicline for smoking cessation in bipolar disorder: A randomized, double-blind, placebo-controlled study","volume":"75","author":"Chengappa","year":"2014","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0065","article-title":"Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states","author":"Colton","year":"2006","journal-title":"Preventing Chronic Disease"},{"key":"10.1016\/bs.irn.2015.08.001_bb0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jama.2013.284985","article-title":"Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation","volume":"311","author":"Cook","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2015.08.001_bb0075","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.4088\/JCP.v69n1109","article-title":"Predictors of early abstinence in smokers with schizophrenia","volume":"69","author":"Culhane","year":"2008","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2015.08.001_bb0080","doi-asserted-by":"crossref","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","article-title":"The preventable causes of death in the United States: Comparative risk assessment of dietary, lifestyle, and metabolic risk factors","volume":"6","author":"Danaei","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1016\/bs.irn.2015.08.001_bb0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-9964(01)00217-1","article-title":"Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders","volume":"56","author":"de Leon","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ps.201200143","article-title":"Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999\u20132011","volume":"64","author":"Dickerson","year":"2013","journal-title":"Psychiatric Services"},{"key":"10.1016\/bs.irn.2015.08.001_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.schres.2004.01.006","article-title":"Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia","volume":"70","author":"Dolan","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archpsyc.58.6.565","article-title":"Quality of medical care and excess mortality in older patients with mental disorders","volume":"58","author":"Druss","year":"2001","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2753\/IMH0020-7411370201","article-title":"Improving the health of mental health consumers: Effective policies and practices","volume":"37","author":"Everett","year":"2008","journal-title":"International Journal of Mental Health"},{"key":"10.1016\/bs.irn.2015.08.001_bb0110","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1176\/appi.ajp.2013.13091257","article-title":"Reassessing the safety of varenicline","volume":"170","author":"Evins","year":"2013","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.jcp.0b013e3180ca86fa","article-title":"A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia","volume":"27","author":"Evins","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.jcp.0000162802.54076.18","article-title":"A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia","volume":"25","author":"Evins","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/HRP.0000000000000063","article-title":"Treatment of tobacco use disorders in smokers with serious mental illness: Toward clinical best practices","volume":"23","author":"Evins","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0130","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.2013.285113","article-title":"Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial","volume":"311","author":"Evins","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2015.08.001_bb0135","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4088\/JCP.v66n0915","article-title":"Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia","volume":"66","author":"Evins","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14622200110073920","article-title":"A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia","volume":"3","author":"Evins","year":"2001","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0145","series-title":"Clinical practice guideline. Executive summary","article-title":"Treating tobacco use and dependence: 2008 update","author":"Fiore","year":"2008"},{"key":"10.1016\/bs.irn.2015.08.001_bb0150","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.biopsych.2007.11.002","article-title":"A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia","volume":"63","author":"George","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-3223(02)01339-2","article-title":"A placebo controlled trial of bupropion for smoking cessation in schizophrenia","volume":"52","author":"George","year":"2002","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0160","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia","volume":"157","author":"George","year":"2000","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0165","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1176\/appi.ajp.2013.12121599","article-title":"Varenicline, smoking cessation, and neuropsychiatric adverse events","volume":"170","author":"Gibbons","year":"2013","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4088\/JCP.v66n0205","article-title":"Medical morbidity and mortality in schizophrenia: Guidelines for psychiatrists","volume":"66","author":"Goff","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0175","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1176\/appi.ajp.2011.10050723","article-title":"Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia","volume":"168","author":"Greenwood","year":"2011","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0180","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1176\/appi.ajp.161.11.2100","article-title":"Extended nortriptyline and psychological treatment for cigarette smoking","volume":"161","author":"Hall","year":"2004","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jamapsychiatry.2013.3726","article-title":"Comorbidity of severe psychotic disorders with measures of substance use","volume":"71","author":"Hartz","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-5618.2011.00943.x","article-title":"The co-occurrence of cigarette smoking and bipolar disorder: Phenomenology and treatment considerations","volume":"13","author":"Heffner","year":"2011","journal-title":"Bipolar Disorders"},{"key":"10.1016\/bs.irn.2015.08.001_bb0195","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1176\/appi.ajp.160.12.2228","article-title":"To whom do psychiatrists offer smoking-cessation counseling?","volume":"160","author":"Himelhoch","year":"2003","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0200","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2011.83","article-title":"Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder","volume":"68","author":"Hong","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0205","first-page":"349","article-title":"Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia","volume":"1","author":"Horst","year":"2005","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/bs.irn.2015.08.001_bb0210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMsa1211128","article-title":"21st-century hazards of smoking and benefits of cessation in the United States","volume":"368","author":"Jha","year":"2013","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.irn.2015.08.001_bb0215","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00213-008-1133-8","article-title":"Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia","volume":"199","author":"Jubelt","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0220","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness: A population-based prevalence study","volume":"284","author":"Lasser","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2015.08.001_bb0225","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(00)00035-2","article-title":"Smoking and schizophrenia: Abnormal nicotinic receptor expression","volume":"393","author":"Leonard","year":"2000","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0230","series-title":"Sixteen state study on mental health performance measures","author":"Lutterman","year":"2003"},{"key":"10.1016\/bs.irn.2015.08.001_bb0235","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2105\/AJPH.2009.188136","article-title":"Smoking characteristics of adults with selected lifetime mental illnesses: Results from the 2007 national health interview survey","volume":"100","author":"McClave","year":"2010","journal-title":"American Journal of Public Health"},{"key":"10.1016\/bs.irn.2015.08.001_bb0240","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","article-title":"Actual causes of death in the United States, 2000","volume":"291","author":"Mokdad","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/bs.irn.2015.08.001_bb0245","unstructured":"Any Mental Illness Among Adults. (2013) (Accessed March 5, 2013, at http:\/\/www.nimh.nih.gov\/statistics\/1ANYDIS_ADULT.shtml)."},{"key":"10.1016\/bs.irn.2015.08.001_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers","volume":"42","author":"Olincy","year":"1997","journal-title":"Biological Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/15504263.2012.663675","article-title":"Varenicline for smoking cessation in schizophrenia: Safety and effectiveness in a 12-week, open-label trial","volume":"8","author":"Pachas","year":"2012","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1016\/bs.irn.2015.08.001_bb0260","series-title":"Morbidity and mortality in people with serious mental illness","author":"Parks","year":"2006"},{"key":"10.1016\/bs.irn.2015.08.001_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(12)61720-6","article-title":"The 21st century hazards of smoking and benefits of stopping: A prospective study of one million women in the UK","volume":"381","author":"Pirie","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/bs.irn.2015.08.001_bb0270","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00213-013-3286-3","article-title":"Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia","volume":"231","author":"Roh","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0275","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/0269881104047273","article-title":"Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders","volume":"18","author":"Sacco","year":"2004","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0280","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.62.6.649","article-title":"Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: Involvement of nicotinic receptor mechanisms","volume":"62","author":"Sacco","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0285","unstructured":"Substance Abuse and Mental Health Service Administration. (2014) (Accessed July 28, 2014, at http:\/\/www.samhsa.gov\/)."},{"key":"10.1016\/bs.irn.2015.08.001_bb0290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002280050394","article-title":"A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers","volume":"53","author":"Schrenk","year":"1998","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0295","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.publhealth.012809.103701","article-title":"Confronting a neglected epidemic: Tobacco cessation for persons with mental illnesses and substance abuse problems","volume":"31","author":"Schroeder","year":"2010","journal-title":"Annual Review of Public Health"},{"key":"10.1016\/bs.irn.2015.08.001_bb0300","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/npp.2011.238","article-title":"Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: A randomized double-blind placebo-controlled trial","volume":"37","author":"Shim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2015.08.001_bb0305","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1360-0443.2009.02545.x","article-title":"Assessing motivation to quit smoking in people with mental illness: A review","volume":"104","author":"Siru","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/bs.irn.2015.08.001_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YPG.0b013e32834c0c33","article-title":"Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia","volume":"22","author":"Stephens","year":"2012","journal-title":"Psychiatric Genetics"},{"key":"10.1016\/bs.irn.2015.08.001_bb0315","unstructured":"Thorndike, A. N., Hoeppner, S. S., Cather, C. Pachas, G. N., Achtyes, E. D., & Evins, A. E. (in press). Weight, cardiovascular risk, and tobacco abstinence in smokers with serious mental illness: A subgroup analysis of a randomized trial. Journal of Clinical Psychiatry."},{"key":"10.1016\/bs.irn.2015.08.001_bb0320","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMsa1211127","article-title":"50-year trends in smoking-related mortality in the United States","volume":"368","author":"Thun","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"Suppl.","key":"10.1016\/bs.irn.2015.08.001_bb0325","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ypmed.2011.11.010","article-title":"Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness","volume":"55","author":"Tidey","year":"2012","journal-title":"Preventive Medicine"},{"key":"10.1016\/bs.irn.2015.08.001_bb0330","doi-asserted-by":"crossref","unstructured":"Tidey, J., & Miller, M. (in press). Smoking cessation and reduction in people with chronic mental illness. BMJ.","DOI":"10.1136\/bmj.h4065"},{"key":"10.1016\/bs.irn.2015.08.001_bb0335","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ntr\/ntn032","article-title":"Intention to quit moderates the effect of bupropion on smoking urge","volume":"11","author":"Tidey","year":"2009","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0340","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.schres.2009.09.032","article-title":"Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls","volume":"115","author":"Tidey","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0345","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00213-011-2282-8","article-title":"Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia","volume":"217","author":"Tidey","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.irn.2015.08.001_bb0350","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007253.pub3","article-title":"Interventions for smoking cessation and reduction in individuals with schizophrenia","volume":"2","author":"Tsoi","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/bs.irn.2015.08.001_bb0355","series-title":"The health consequences of smoking: A report of the surgeon genera","author":"USDHHS","year":"2004"},{"key":"10.1016\/bs.irn.2015.08.001_bb0360","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.schres.2006.12.007","article-title":"Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia","volume":"91","author":"Weinberger","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0365","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4088\/JCP.10m06143gre","article-title":"Bupropion sustained release added to group support for smoking cessation in schizophrenia: A new randomized trial and a meta-analysis","volume":"73","author":"Weiner","year":"2012","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0370","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.schres.2011.02.003","article-title":"Varenicline for smoking cessation in people with schizophrenia: A double blind randomized pilot study","volume":"129","author":"Weiner","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0375","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thorax.55.12.987","article-title":"Smoking cessation guidelines for health professionals: An update. Health education authority","volume":"55","author":"West","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/bs.irn.2015.08.001_bb0380","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.11m07522","article-title":"A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder","volume":"73","author":"Williams","year":"2012","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/bs.irn.2015.08.001_bb0385","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.04.016","article-title":"Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect","volume":"79","author":"Williams","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0390","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.schres.2010.10.011","article-title":"Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia","volume":"128","author":"Wing","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1016\/bs.irn.2015.08.001_bb0395","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/15504263.2012.671067","article-title":"A preliminary feasibility study of varenicline for smoking cessation in bipolar disorder","volume":"8","author":"Wu","year":"2012","journal-title":"Journal of Dual Diagnosis"},{"key":"10.1016\/bs.irn.2015.08.001_bb0400","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003088-199936060-00004","article-title":"Drug interactions with tobacco smoking. An update","volume":"36","author":"Zevin","year":"1999","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/bs.irn.2015.08.001_bb0405","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/14622200802443569","article-title":"Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report","volume":"10","author":"Ziedonis","year":"2008","journal-title":"Nicotine & Tobacco Research"}],"container-title":["International Review of Neurobiology","Nicotine Use in Mental Illness and Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774215000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774215000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T07:51:46Z","timestamp":1537343506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774215000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9780128015834"],"references-count":81,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2015.08.001","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}